Clinical trial

SAR240550 in Combination With Gemcitabine/Cisplatin in Non-small Cell Lung Cancer

NCT01086254

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Iniparib Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record gemcitabine Normalized identity: gemcitabineView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record cisplatin Normalized identity: cisplatinView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

SAR240550 in Combination With Gemcitabine/Cisplatin in Non-small Cell Lung Cancer

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-05-01

PhasePHASE2

Conditions

Non-small Cell Lung Cancer Stage IVunresolved

Interventions

IniparibDRUG

gemcitabineDRUG · verified · RxNorm: gemcitabine

cisplatinDRUG · verified · RxNorm: cisplatin

Sponsors & collaborators

Sanofilead sponsor

Mapped research locations

BarcelonaSpain1 ToulouseFrance1 MarseilleFrance1 EssenGermany1 CaenFrance1 VillejuifFrance1 Newcastle upon TyneUnited Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01086254 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.